|
市場調查報告書
亞太地區的生物科技市場：市場預測（∼2012年）
Asia Pacific Biotechnology Market (2008-2012)
|
本報告已在2011年06月23日停止出版。
更改為出版
Asia Pacific Biotechnology Market (2008-2012)
出版日期 : 2011年06月
商品編碼: 200351
本報告，調查分析亞太地區生物科技市場的現狀與展望，並彙整主要國家的市場概要、市場成長牽引因子/阻礙因子、政府的規範・獎勵行動、主要企業的檔案資料、市場規模實績・預測（∼2012年）、生物科技的新市場區塊的動向等，由下列摘要形式闡述。
第1章 分析師的見解
第2章 亞太地區的生物科技市場
第3章 產業動向
- 共同研究・策略合作
- 跨國企業的大型投資
- 癌症・H1N1流感
第4章 新市場區塊
- 委外研究・製造
- 生物仿製藥
- 疫苗
- 學名藥
- 幹細胞的相關研究
- 生物資訊學
第5章 生物科技市場的展望：∼2012年
- 日本
- 中國
- 印度
- 澳洲
- 台灣
- 韓國
- 紐西蘭
- 新加坡
- 馬來西亞
- 市場概要
- 市場成長牽引因子•阻礙因子
- 政府的規範・獎勵行動
- 主要企業
圖表
Abstract
The biotechnology market in the Asia-Pacific region seems very lucrative from
investment perspective, as it has enjoyed double-digit growth during the past
few years. The industry is attracting more and more private investments in
wake of immense growth opportunities and vast untapped biotech markets.
Identifying the future growth potential of the industry, the governments of
different countries in the Asia-Pacific region are taking up various
initiatives to promote research in this region. Overall, the Asia-Pacific
biotech market is expected to spur future growth in the global biotechnology
market.
According to our new research report, “Asia Pacific Biotechnology
Market (2008-2012)”, the Asia-Pacific biotech market is projected to
grow at a CAGR of around 16% during 2010 - 2012. Our research has found that
at the regional forefront, Japan and China are dominating this industry, while
higher growth rates have been witnessed in emerging markets like Malaysia,
India, and Singapore. These countries are anticipated to dominate the market
in future with combined share of around 70% of overall market.
In depth analysis of the market has shown that various factors such as
emerging biosimilar market and various others discussed in the report will
drive the future growth of the industry. On account of wide application areas
ranging from infectious diseases to autoimmune diseases, companies have
started research and development programs on developing biosimilars to acquire
the market space as soon as possible.
The report also provides extensive information and data of the biotech market
in the Asia-Pacific region. The report also discusses the emerging trends like
contract research and manufacturing, bioinformatics, generics market etc. It
provides valuable information to pharmaceutical & biotechnology companies and
investors, planning to enter these markets and will help them to devise
strategies in accordance to the individual markets. The report also contains
detailed analysis and statistics of the market size, growth, share,
segmentation, geographic distribution, trends in technology development, and
profiling of key players of each country.
Table of Contents
1. Analyst View
2. Asia-Pacific Biotechnology Market
- 2.1 Market Overview
- 2.1.1 Product Segmentation
- 2.1.2 Geographical Segmentation
3. Industry Trends
- 3.1 Collaborations and Strategic Alliances
- 3.2 MNCs Foraying Heavy Investments
- 3.3 Focus on Oncology and H1N1 Influenza
4. Emerging Sectors
- 4.1 Contract Research and Manufacturing
- 4.2 Biosimilars
- 4.3 Vaccines
- 4.4 Generics
- 4.5 Stem Cell Research
- 4.6 Bioinformatics
5. Biotechnology Market Outlook to 2012
- 5.1 Japan
- 5.1.1 Market Overview
- 5.1.2 Drivers and Restraints
- 5.1.3 Government Regulations and Initiatives
- 5.1.4 Key Players
- 5.2 China
- 5.2.1 Market Overview
- 5.2.2 Drivers and Restraints
- 5.2.3 Government Regulations and Initiatives
- 5.2.4 Key Players
- 5.3 India
- 5.3.1 Market Overview
- 5.3.2 Drivers and Restraints
- 5.3.3 Government Regulations and Initiatives
- 5.3.4 Key Players
- 5.4 Australia
- 5.4.1 Market Overview
- 5.4.2 Drivers and Restraints
- 5.4.3 Government Regulations and Initiatives
- 5.4.4 Key Players
- 5.5 Taiwan
- 5.5.1 Market Overview
- 5.5.2 Drivers and Restraints
- 5.5.3 Government Regulations and Initiatives
- 5.5.4 Key Players
- 5.6 South Korea
- 5.6.1 Market Overview
- 5.6.2 Drivers and Restraints
- 5.6.3 Government Regulations and Initiatives
- 5.6.4 Key Players
- 5.7 New Zealand
- 5.7.1 Market Overview
- 5.7.2 Drivers and Restraints
- 5.7.3 Government Regulations and Initiatives
- 5.7.4 Key Players
- 5.8 Singapore
- 5.8.1 Market Overview
- 5.8.2 Drivers and Restraints
- 5.8.3 Government Regulations and Initiatives
- 5.8.4 Key Players
- 5.9 Malaysia
- 5.9.1 Market Overview
- 5.9.2 Drivers and Restraints
- 5.9.3 Government Regulations and Initiatives
- 5.9.4 Key Players
List of Figures:
- Figure 2-1: Asia-Pacific - Biotechnology Market (Billion US$), 2008-2012
- Figure 2-2: Asia-Pacific - Biotechnology Market by Segment (%), 2009
- Figure 2-3: Asia-Pacific - Biotechnology Market by Country (%), 2009
- Figure 2-4: Forecast for Asia-Pacific Biotechnology Market by Country (%),
2012
- Figure 4-1: India - Contract Research Market (Million US$), 2008-2010
- Figure 4-2: India - Contract Manufacturing Market (Million US$), 2008-2010
- Figure 4-3: Asia-Pacific - Generics Market (Billion US$), 2007-2009
- Figure 5-1: Japan - Biotechnology Market (Billion US$), 2008-2012
- Figure 5-2: Japan - Biotechnology Market by Segment (%), 2010
- Figure 5-3: Japan - Medical and Healthcare Biotechnology Market by Segment
(%), 2007
- Figure 5-4: Japan - Geographical Distribution of Bio-clusters
- Figure 5-5: China - Biotechnology Market (Billion US$), 2008-2012
- Figure 5-6: China - Biotechnology Market by Segment (%), 2010
- Figure 5-7: India - Biotechnology Market (Billion INR), FY 2008 to FY 2012
- Figure 5-8: India - Export and Domestic Consumption of Biotechnology
Market (%), FY 2010
- Figure 5-9: India - Biotechnology Market by Segment (%), FY 2010
- Figure 5-10: India - Biopharmaceutical Market by Segment (%), FY 2007
- Figure 5-11: India - Forecast for Biotechnology Market by Segment (%), FY
2012
- Figure 5-12: India - Geographical Distribution of Bio-clusters
- Figure 5-13: Australia - Biotechnology Market (Billion US$), 2008-2012
- Figure 5-14: Australia - Biotechnology Companies by Sector (%), June 2008
- Figure 5-15: Australia - Geographical Distribution of Bio-clusters
- Figure 5-16: Taiwan - Biotechnology Market (Billion US$), 2008-2012
- Figure 5-17: South Korea - Biotechnology Market (Billion US$), 2008-2012
- Figure 5-18: South Korea - Biotechnology Market by Segment (%)
- Figure 5-19: South Korea - Geographical Distribution of Bio-clusters
- Figure 5-20: New Zealand - Biotechnology Market (Million US$), 2008-2012
- Figure 5-21: New Zealand - Biotechnology Market by Application (%), 2009
- Figure 5-22: New Zealand - Biotechnology Companies by Sector (%), 2007
- Figure 5-23: New Zealand - Geographical Distribution of Bio-clusters
- Figure 5-24: Singapore - Biotechnology Market (Million US$), 2008-2012
- Figure 5-25: Singapore - Geographical Distribution of Bio-clusters
- Figure 5-26: Malaysia - Biotechnology Market (Million RM), 2008-2012
- Figure 5-27: Malaysia - Biotechnology Industry Investment by Segment (%)
|
